Un nuevo ensayo de IgE múltiple específico - MAST.

Same author

Defective macrophage handling of Escherichia coli in Crohn's disease.

Journal of gastroenterology and hepatology·2015

Same author

Dietary intervention for oral allergy syndrome as a treatment in orofacial granulomatosis: a new approach?

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·2013

Same author

Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.

Neurogastroenterology and motility·2011

Same author

Food sensitivity and rheumatoid arthritis.

Environmental toxicology and pharmacology·2011

Same author

BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.

British journal of cancer·2008

Same author

A diabetic life before and after the insulin era.

Diabetologia·2007

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Un nuevo ensayo de IgE múltiple específico - MAST.

Videos de Conceptos Relacionados

Defective macrophage handling of Escherichia coli in Crohn's disease.

Dietary intervention for oral allergy syndrome as a treatment in orofacial granulomatosis: a new approach?

Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.

Food sensitivity and rheumatoid arthritis.

BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.

A diabetic life before and after the insulin era.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Un nuevo ensayo de IgE múltiple específico - MAST.

Videos de Conceptos Relacionados

Artículos Relacionados

Defective macrophage handling of Escherichia coli in Crohn's disease.

Dietary intervention for oral allergy syndrome as a treatment in orofacial granulomatosis: a new approach?

Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.

Food sensitivity and rheumatoid arthritis.

BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.

A diabetic life before and after the insulin era.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.